Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Mar 2026 is -8.46% vs -13.11% in Mar 2025
Consolidate Net Profit
YoY Growth in quarter ended Mar 2026 is -74.47% vs -27.07% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Mar 2026 is -83.85% vs -19.33% in Mar 2025
Interest
YoY Growth in quarter ended Mar 2026 is 40.00% vs 75.00% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025
Compare Quarterly Results Of Pacific Shuanglin Bio-pharmacy Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2026 is -66.20% vs 60.60% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -8.46% vs -13.11% in Mar 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is -63.39% vs -49.01% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -74.47% vs -27.07% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is -82.91% vs -28.56% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -83.85% vs -19.33% in Mar 2025
Quarterly - Interest
QoQ Growth in quarter ended Mar 2026 is -9.26% vs -6.90% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 40.00% vs 75.00% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025
YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025






